Arterial dysfunction and functional performance in patients with peripheral artery disease: A review

Vascular Medicine

Volumn 16, Issue 3, 2011, Pages 203-211

  Coutinho, Thais ^a   Rooke, Thom W ^a   Kullo, Iftikhar J ^a  

^a MAYO CLINIC   (United States)

Author keywords

arterial stiffness; endothelial dysfunction; exercise; functional performance; peripheral artery disease

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ADENOSINE; AMLODIPINE; ASCORBIC ACID; ATENOLOL; BENDROFLUMETHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PERINDOPRIL; RAMIPRIL;

AEROBIC EXERCISE; ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FUNCTIONAL STATUS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; WALKING;

ANKLE BRACHIAL INDEX; ARTERIES; COMPLIANCE; DIAGNOSTIC IMAGING; ENDOTHELIUM, VASCULAR; EXERCISE TEST; EXERCISE THERAPY; HEMODYNAMICS; HUMANS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79959207961     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X11400935     Document Type: Review

References (75)

1. Criqui MH Peripheral arterial disease-epidemiological aspects. Vasc Med 2001 ; 6: 3-7.
2. McDermott MM The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med 2006 ; 73 (suppl 4). S2-7.
3. Pell JP Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995 ; 9: 469-472.
4. Izquierdo-Porrera AM, Gardner AW, Bradham DD, et al. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg 2005 ; 41: 625-630. (Pubitemid 40637661)
5. Tsai JC, Chan P., Wang CH, et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002 ; 252: 448-455. (Pubitemid 36706576)
6. Szuba A., Oka RK, Harada R., Cooke JP Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 2006 ; 11: 155-163. (Pubitemid 46099259)
7. Parr B., Noakes TD, Derman EW Factors predicting walking intolerance in patients with peripheral arterial disease and intermittent claudication. S Afr Med J 2008 ; 98: 958-962.
8. Gardner AW, Skinner JS, Cantwell BW, Smith LK Prediction of claudication pain from clinical measurements obtained at rest. Med Sci Sports Exerc 1992 ; 24: 163-170.
9. Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology 1993 ; 44: 1-10. (Pubitemid 23033195)
10. Binder J., Bailey KR, Seward JB, et al. Aortic augmentation index is inversely associated with cardiorespiratory fitness in men without known coronary heart disease. Am J Hypertens 2006 ; 19: 1019-1024. (Pubitemid 44485958)
11. DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000 ; 102: 1351-1357.
12. Pierce GL, Eskurza I., Walker AE, Fay TN, Seals DR Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci (Lond) 2010 ; 120: 13-23.
13. Seals DR, Tanaka H., Clevenger CM, et al. Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol 2001 ; 38: 506-513. (Pubitemid 32721781)
14. Brewer LC, Chai HS, Bailey KR, Kullo IJ Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease. Atherosclerosis 2007 ; 191: 384-390. (Pubitemid 46400700)
15. Gardner AW, Skinner JS, Cantwell BW, Smith LK Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 1991 ; 23: 402-408.
16. McDermott MM, Ades PA, Dyer A., Guralnik JM, Kibbe M., Criqui MH Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 2008 ; 48: 1231-1237, 1237 e1.
17. McDermott MM, Tian L., Liu K., et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 2008 ; 51: 1482-1489. (Pubitemid 351492522)
18. Gardner AW, Montgomery PS, Parker DE Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg 2008 ; 47: 117-122.
19. McDermott MM, Ades P., Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009 ; 301: 165-174.
20. Spronk S., Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training-randomized controlled trial. Radiology 2009 ; 250: 586-595.
21. Murphy TP, Hirsch AT, Ricotta JJ, et al. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg 2008 ; 47: 1356-1363.
22. Murphy TP, Hirsch AT, Cutlip DE, et al. Claudication: exercise vs endoluminal revascularization (CLEVER) study update. J Vasc Surg 2009 ; 50: 942-945, e 942.
23. Kullo IJ, Malik AR Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol 2007 ; 49: 1413-1426. (Pubitemid 46482924)
24. Liao JK, Bettmann MA, Sandor T., Tucker JI, Coleman SM, Creager MA Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res 1991 ; 68: 1027-1034.
25. Muller-Buhl U., Wiesemann A., Oser B., Kirchberger I., Strecker EP Correlation of hemodynamic and functional variables with the angiographic extent of peripheral arterial occlusive disease. Vasc Med 1999 ; 4: 247-251. (Pubitemid 30010576)
26. McDermott MM, Ferrucci L., Guralnik JM, et al. The ankle- brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med 2010 ; 15: 251-257.
27. McDermott MM, Liu K., Guralnik JM, et al. The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease. J Am Geriatr Soc 1998 ; 46: 1355-1362. (Pubitemid 28511875)
28. Amoh-Tonto CA, Malik AR, Kondragunta V., Ali Z., Kullo IJ Brachial-ankle pulse wave velocity is associated with walking distance in patients referred for peripheral arterial disease evaluation. Atherosclerosis. 2009 ; 206: 173-178.
29. Parmenter BJ, Raymond J., Fiatarone Singh MA The effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials. Sports Med 2010 ; 40: 433-447.
30. Gardner AW, Montgomery PS The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication. J Vasc Surg 2008 ; 47: 1251-1258.
31. Ryan AS, Katzel LI, Gardner AW Determinants of peak V(O2) in peripheral arterial occlusive disease patients. J Gerontol A Biol Sci Med Sci 2000 ; 55: B302-306.
32. Anderson JD, Epstein FH, Meyer CH, et al. Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol 2009 ; 54: 628-635.
33. Brass EP, Hiatt WR Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 2000 ; 5: 55-59. (Pubitemid 30143363)
34. Bauer TA, Brass EP, Hiatt WR Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg 2004 ; 40: 488-493. (Pubitemid 39165024)
35. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 ; 27: 2588-2605. (Pubitemid 44627304)
36. Mattace-Raso FU, van der Cammen TJ, Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006 ; 113: 657-663.
37. Gallagher D., Adji A., O'Rourke MF Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens 2004 ; 17: 1059-1067. (Pubitemid 39469331)
38. Castagna O., Boussuges A., Nussbaum E., Marqueste L., Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil 2008 ; 15: 270-277.
39. Malik AR, Kondragunta V., Kullo IJ Forearm vascular reactivity and arterial stiffness in asymptomatic adults from the community. Hypertension 2008 ; 51: 1512-1518.
40. Mitchell GF, Vita JA, Larson MG, et al. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005 ; 112: 3722-3728. (Pubitemid 43739512)
41. Brevetti G., Schiano V., Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis 2008 ; 197: 1-11.
42. Verma S., Anderson TJ Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002 ; 105: 546-549. (Pubitemid 34123425)
43. Moens AL, Goovaerts I., Claeys MJ, Vrints CJ Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 2005 ; 127: 2254-2263.
44. Terai M., Ohishi M., Ito N., et al. Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study. Hypertens Res 2008 ; 31: 1135-1145.
45. Adams MR Clinical assessment of endothelial function. Endothelium 2006 ; 13: 367-374. (Pubitemid 44941969)
46. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002 ; 39: 257-265. (Pubitemid 34084631)
47. Monsuez JJ [Mediators of reactive hyperemia]. Arch Mal Coeur Vaiss. 2001 ; 94: 591-599.
48. Tagawa T., Imaizumi T., Endo T., Shiramoto M., Harasawa Y., Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994 ; 90: 2285-2290. (Pubitemid 24354313)
49. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P., Creager MA Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996 ; 270: H1435-1440.
50. Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol 1999 ; 83: 754-758. (Pubitemid 29115450)
51. Joras M., Poredos P. The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease. Vasc Med 2008 ; 13: 255-262.
52. Payvandi L., Dyer A., McPherson D., et al. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med 2009 ; 14: 193-201.
53. Isbell DC, Epstein FH, Zhong X., et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first-pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2007 ; 25: 1013-1020. (Pubitemid 46697572)
54. Clifford PS, Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J Appl Physiol 2004 ; 97: 393-403. (Pubitemid 38802543)
55. Ellsworth ML, Forrester T., Ellis CG, Dietrich HH The erythrocyte as a regulator of vascular tone. Am J Physiol 1995 ; 269: H2155-2161.
56. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 1999 ; 194 (Pt 3). 335-342. (Pubitemid 29241485)
57. Rosenmeier JB, Hansen J., Gonzalez-Alonso J. Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 2004 ; 558: 351-365. (Pubitemid 39077414)
58. Rosenmeier JB, Yegutkin GG, Gonzalez-Alonso J. Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle. J Physiol 2008 ; 586: 4993-5002.
59. Mortensen SP, Nyberg M., Thaning P., Saltin B., Hellsten Y. Adenosine contributes to blood flow regulation in the exercising human leg by increasing prostaglandin and nitric oxide formation. Hypertension 2009 ; 53: 993-999.
60. Goldberg Y., Boaz M., Matas Z., Goldberg I., Shargorodsky M. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Clin Nutr 2009 ; 28: 21-25.
61. Aizawa K., Shoemaker JK, Overend TJ, Petrella RJ Effects of lifestyle modification on central artery stiffness in metabolic syndrome subjects with pre-hypertension and/or pre-diabetes. Diabetes Res Clin Pract 2009 ; 83: 249-256.
62. Collier SR, Kanaley JA, Carhart R. Jr, et al. Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives. J Hum Hypertens 2008 ; 22: 678-686.
63. Vona M., Codeluppi GM, Iannino T., Ferrari E., Bogousslavsky J., von Segesser LK Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction. Circulation 2009 ; 119: 1601-1608.
64. Walther G., Nottin S., Karpoff L., Perez-Martin A., Dauzat M., Obert P. Flow-mediated dilation and exercise-induced hyperaemia in highly trained athletes: comparison of the upper and lower limb vasculature. Acta Physiol (Oxf) 2008 ; 193: 139-150. (Pubitemid 351661595)
65. Mukherjee S., Mukhopadhyay P., Pandit K., Mukherjee S., Chowdhury S. Atorvastatin improves arterial stiffness in normotensive normolipidaemic persons with type 2 diabetes. J Indian Med Assoc 2008 ; 106: 716-719.
66. Laufs U., La Fata V., Plutzky J., Liao JK Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 ; 97: 1129-1135. (Pubitemid 28152885)
67. Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T., Lindholt JS Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009 ; 38: 463-474.
68. Giri J., McDermott MM, Greenland P., et al. Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 2006 ; 47: 998-1004.
69. McDermott MM, Guralnik JM, Greenland P., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 2003 ; 107: 757-761. (Pubitemid 36222606)
70. Williams B., Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006 ; 113: 1213-1225.
71. Ahimastos AA, Natoli AK, Lawler A., Blombery PA, Kingwell BA Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005 ; 45: 1194-1199. (Pubitemid 40770326)
72. Ahimastos AA, Dart AM, Lawler A., Blombery PA, Kingwell BA Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients. J Hypertens 2008 ; 26: 1037-1042. (Pubitemid 351520993)
73. Mombouli JV, Vanhoutte PM Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 1999 ; 31: 61-74. (Pubitemid 29078219)
74. Silvestro A., Scopacasa F., Oliva G., de Cristofaro T., Iuliano L., Brevetti G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 2002 ; 165: 277-283. (Pubitemid 35333354)
75. Gresele P., Migliacci R., Procacci A., De Monte P., Bonizzoni E. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost 2007 ; 97: 444-450. (Pubitemid 46437807)